Cargando…
Adjunctive therapies and immunomodulatory agents in the management of severe influenza
In addition to neuraminidase inhibitors and other drugs that directly target viral replication, a number of adjunctive and immunomodulatory therapies are currently under evaluation for the treatment of influenza. These novel treatments, which focus either on pathophysiological aspects of influenza v...
Autores principales: | Hui, David S., Lee, Nelson, Chan, Paul K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132367/ https://www.ncbi.nlm.nih.gov/pubmed/23578727 http://dx.doi.org/10.1016/j.antiviral.2013.03.019 |
Ejemplares similares
-
Adjunctive therapies and immunomodulating agents for severe influenza
por: Hui, David S. C., et al.
Publicado: (2013) -
The role of adjuvant immunomodulatory agents for treatment of severe influenza
por: Hui, David S., et al.
Publicado: (2018) -
Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis
por: Zumla, Alimuddin, et al.
Publicado: (2016) -
The cytokine storm of severe influenza and development of immunomodulatory therapy
por: Liu, Qiang, et al.
Publicado: (2016) -
Passive immune therapy and other immunomodulatory agents for the treatment of severe influenza: Systematic review and meta‐analysis
por: Lim, Vanessa W., et al.
Publicado: (2019)